Dose-dependent artifact in the far wall of the carotid artery at dynamic contrast-enhanced US

Radiology

Volumn 262, Issue 2, 2012, Pages 672-679

  Thapar, Ankur ^a   Shalhoub, Joseph ^a   Averkiou, Michalakis ^b   Mannaris, Christophoros ^b   Davies, Alun H ^a   Leen, Edward L S ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CYPRUS   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERY WALL; ARTICLE; ARTIFACT; CAROTID ARTERY; CASE STUDY; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTRAST ENHANCEMENT; ECHOGRAPHY; FEMALE; HUMAN; IMAGE DISPLAY; IMAGE ENHANCEMENT; IMAGE QUALITY; IN VITRO STUDY; IN VIVO STUDY; MALE; PHANTOM; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS;

AGED; AGED, 80 AND OVER; ARTIFACTS; CAROTID ARTERIES; CAROTID STENOSIS; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; PHOSPHOLIPIDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY;

EID: 84857408024     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11110968     Document Type: Article

References (22)

1. Shalhoub J, Owen DR, Gauthier T, Monaco C, Leen EL, Davies AH. The use of contrast enhanced ultrasound in carotid arterial disease. Eur J Vasc Endovasc Surg 2010; 39(4):381-387.
2. Staub D, Schinkel AF, Coll B, et al. Contrastenhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging 2010;3(7):761-771.
3. Moreno PR, Purushothaman KR, Fuster V, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 2004;110(14): 2032-2038. (Pubitemid 39331918)
4. Dunmore BJ, McCarthy MJ, Naylor AR, Brindle NP. Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques. J Vasc Surg 2007;45(1):155-159. (Pubitemid 46038656)
5. Michel JB, Virmani R, Arbustini E, Pasterkamp G. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J 2011;32(16):1977-1985, 1985a, 1985b, 1985c.
6. Doyle B, Caplice N. Plaque neovascularization and antiangiogenic therapy for atherosclerosis . J Am Coll Cardiol 2007;49(21): 2073-2080. (Pubitemid 46771052)
7. Cosgrove D, Lassau N. Imaging of perfusion using ultrasound. Eur J Nucl Med Mol Imaging 2010;37(Suppl 1):S65-S85.
8. Shah F, Balan P, Weinberg M, et al. Contrastenhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis? Vasc Med 2007;12(4):291-297.
9. Faggioli GL, Pini R, Mauro R, et al. Identification of carotid 'vulnerable plaque' by contrast-enhanced ultrasonography: correlation with plaque histology, symptoms and cerebral computed tomography. Eur J Vasc Endovasc Surg 2011;41(2):238-248.
10. Magnoni M, Coli S, Marrocco-Trischitta MM, et al. Contrast-enhanced ultrasound imaging of periadventitial vasa vasorum in human carotid arteries. Eur J Echocardiogr 2009; 10(2):260-264.
11. Staub D, Partovi S, Schinkel AF, et al. Correlation of carotid artery atherosclerotic lesion echogenicity and severity at standard US with intraplaque neovascularization detected at contrast-enhanced US. Radiology 2011;258(2):618-626.
12. Coli S, Magnoni M, Sangiorgi G, et al. Contrast- enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity . J Am Coll Cardiol 2008;52(3):223-230. (Pubitemid 351915779)
13. Xiong L, Deng YB, Zhu Y, Liu YN, Bi XJ. Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms. Radiology 2009; 251(2):583-589.
14. Tang MX, Eckersley RJ. Nonlinear propagation of ultrasound through microbubble contrast agents and implications for imaging . IEEE Trans Ultrason Ferroelectr Freq Control 2006;53(12):2406-2415. (Pubitemid 46115806)
15. Yu H, Jang HJ, Kim TK, et al. Pseudoenhancement within the local ablation zone of hepatic tumors due to a nonlinear artifact on contrast-enhanced ultrasound. AJR Am J Roentgenol 2010;194(3):653-659.
16. Averkiou M, Mannaris C, Nicolaides A. Vascular ultrasound imaging with contrast agents: carotid plaque neovascularization and the hyperplastic vasa vasorum network. In: Nicolaides A, Beach KW, Kyriacou E, Pattichis CS, eds. Ultrasound and carotid bifurcation atherosclerosis. London, England: Springer (in press).
17. Oates CP, Naylor AR, Hartshorne T, et al. Joint recommendations for reporting carotid ultrasound investigations in the United Kingdom. Eur J Vasc Endovasc Surg 2009; 37(3):251-261.
18. Geleijnse ML, Nemes A, Vletter WB, et al. Adverse reactions after the use of sulphur hexafluoride (SonoVue) echo contrast agent. J Cardiovasc Med (Hagerstown) 2009;10(1): 75-77.
19. Morel DR, Schwieger I, Hohn L, et al. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 2000;35(1):80-85. (Pubitemid 30033610)
20. Huang PT, Chen CC, Aronow WS, et al. Assessment of neovascularization within carotid plaques in patients with ischemic stroke. World J Cardiol 2010;2(4):89-97.
21. Staub D, Patel MB, Tibrewala A, et al. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke 2010; 41(1):41-47.
22. Owen DR, Shalhoub J, Miller S, et al. Inflammation within carotid atherosclerotic plaque: assessment with late-phase contrast- enhanced US. Radiology 2010;255(2):638-644.